Eye Health Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Ingredient Type, By Indication, By Formulation, By Region & Competition, 2021-2031F

The Global Eye Health Supplements Market is projected to expand from USD 3.02 Billion in 2025 to USD 5.13 Billion by 2031, registering a CAGR of 9.23%. These dietary products, utilizing bioactive components like zeaxanthin, lutein, vitamins, and omega-3 fatty acids, are designed to enhance physiological ocular function and visual acuity. Growth in this sector is largely fueled by an aging global demographic prone to age-related macular degeneration, alongside a dramatic increase in digital eye strain caused by contemporary lifestyle choices. Highlighting the severity of this visual stress, the American Optometric Association reported in 2024 that over 104 million working-age Americans spend more than seven hours daily viewing screens, driving the need for preventative nutritional support and distinguishing this market through its focus on biological vulnerabilities linked to longevity and device use.

However, the market faces a substantial obstacle in the form of a complex regulatory landscape that governs product approvals and health claims across various nations. Discrepancies in standards regarding labeling and ingredient efficacy pose significant hurdles for manufacturers striving to harmonize global distribution and ensure compliance. This fragmentation in regulations can retard product launches and escalate operational expenses, ultimately hindering the pace at which innovations reach consumers and restricting market penetration in developing regions.

Market Driver

A primary catalyst for market growth is the rapid increase in the global geriatric population and the associated rise in age-related macular degeneration (AMD). As life expectancy extends, the biological inevitability of macular degradation necessitates nutritional interventions to protect central vision, creating sustained demand for high-dose antioxidant supplements like the AREDS2 formulation that are clinically proven to slow disease progression. Underscoring this critical need, data released by the Centers for Disease Control and Prevention in May 2024 indicates that the prevalence of AMD among adults aged 85 and older has reached approximately 46.6%, highlighting the urgency for therapeutic supplementation within this growing demographic.

Concurrently, the rising incidence of digital eye strain is altering consumer behavior by pushing younger generations toward proactive ocular nutrition. The widespread exposure to high-energy visible (HEV) blue light from digital devices has led to an increase in visual fatigue and dry eye, prompting a transition from reactive treatments to preventative care. In February 2024, CooperVision reported that nearly 69% of surveyed adults experienced symptoms linked to digital eye strain, illustrating the pervasive nature of this issue. This trend is further reinforced by long-term refractive challenges; the Association of Optometrists estimated in October 2024 that the global prevalence of myopia among children and young people currently stands at 30.47%, signaling a robust future market for vision-supporting nutraceuticals.

Market Challenge

The Global Eye Health Supplements Market encounters a formidable barrier in the form of a complex regulatory environment controlling product approvals and health claims. Manufacturers must navigate a fragmented legal landscape where inconsistent requirements for labeling and ingredient efficacy compel them to alter marketing strategies or reformulate products for specific jurisdictions. This obligation to adhere to disparate national laws significantly raises compliance costs and extends the lead time for new product introductions, thereby stalling the global scalability of effective visual support formulations and slowing the distribution of advanced eye care solutions to emerging markets where they are needed most.

According to the European Federation of Associations of Health Product Manufacturers (EHPM), the industry faced persistent legal uncertainty in 2024 as over 2,000 botanical health claims remained suspended pending a harmonized assessment. For the eye health sector, which depends heavily on bioactive botanical ingredients such as saffron and bilberry, this regulatory stagnation directly prevents manufacturers from effectively communicating specific product benefits to consumers. As a result, companies are reluctant to invest in clinical validation for new ingredients, aware that regulatory bottlenecks may preclude them from making substantiated health claims on packaging, which ultimately dampens overall market growth.

Market Trends

The development of pediatric vision health portfolios is swiftly advancing from a niche category into a scientifically validated market segment. Manufacturers are transitioning beyond general multivitamins to create specialized, clinically substantiated ocular formulations intended to mitigate the physiological effects of early-life screen exposure, a trend marked by significant investment in research to prove safety and efficacy for younger users. In findings presented at SupplySide West in October 2024, Kemin Industries highlighted a clinical study on adolescents showing that daily supplementation with zeaxanthin and lutein led to a 14% increase in macular pigment optical density, offering the biological evidence needed to support the commercialization of targeted vision products for teenagers.

Simultaneously, the incorporation of nootropics for dual eye-brain health benefits is transforming product development as consumers increasingly demand functional stacks that support both cognitive stress management and visual performance. This convergence drives the inclusion of cognitive enhancers and adaptogens into traditional eye care formulas to address the mental fatigue linked to prolonged focus. The demand for these cross-category benefits is reflected in the rising popularity of key nootropic ingredients; according to the Council for Responsible Nutrition's '2024 Consumer Survey' from October 2024, usage of ashwagandha reached 8% among all supplement users, representing a four-fold increase since 2020 and indicating a strong market appetite for the stress-relief and cognitive support features now being integrated into advanced eye health regimens.

Key Market Players

• Bausch + Lomb
• Alcon
• Danone S.A
• Novartis AG
• Nestle HealthCare Nutrition, Inc.
• DSM
• GlaxoSmithKline
• Pfizer Consumer
• Jamieson
• Jarrow Formulas

Report Scope

In this report, the Global Eye Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Eye Health Supplements Market, By Ingredient Type

• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Eye Health Supplements Market, By Indication

• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Eye Health Supplements Market, By Formulation

• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Eye Health Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Eye Health Supplements Market.

Available Customizations:

Global Eye Health Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).